None listed
Conditions
Brief summary
This trial aims to determine the effect of cognitive bias modification on fear of cancer recurrence or progression in patients with breast and ovarian cancer. Who is it for? You may be eligible for this study if you are aged 18 or above, have been diagnosed with a breast or ovarian cancer (unless you are receiving palliative care), and are currently struggling with a fear of cancer recurrence or progression. Study details Participants will be randomly allocated (by chance) to receive cognitive bias modification training (CBM) or a placebo. . CBM is an intervention that is administered online and trains people not to interpret ambiguous situations in a threatening way. Participants will receive four cognitive bias modification sessions over the duration of 14 days and will be required to answer a number of questionnaires before the trial, and both 14 and 28 days after the trial has commenced. It is hoped that this study may demonstrate that cognitive bias modification is effective in reducing fear of cancer recurrence and progression in patients with breast and ovarian cancer, and may help to reduce pain, anxiety, and depression, and improve quality of life.
Interventions
For this study, we will adopt a double-blind randomized controlled trial methodology, whereby the cancer survivors would be randomly allocated in one of two groups: (1) Cognitive Bias Modification intervention (2) A placebo control. Cognitive Bias Modification for Interpretation (CBM-I): The Word Sentence Association Paradigm (WSAP) will be used to modify interpretation bias with word-sentence pairings training participants to make a benign interpretation of these pairings. In a typical WSAP task (Beard & Amir, 2009), each trial begins with a fixation cross for 500 ms and participants are presented with a single word (benign or threatening) followed by an ambiguous sentence, and indicate whether the two are related or not. That is, participants decide whether or not a word (e.g., embarrassing) is related to an ambiguous sentence (e.g., people laugh after something you said). Each CBM-I session would last approximately for 10-15 minutes. Some participants may be asked to rate each situation based on how worrying each situation is for them. This may take an additional 15 minutes. The intervention will be delivered entirely online by an institutional software program (Qualtrics) that will randomly allocate participants in one of two groups. CBM-I will be delivered four times to each participant during the entire study. Time frame: CBM-I training session 1: day 1 of the study CBM-I training session 2: day 4 of the study CBM-I training session 3: day 7 of the study CBM-I training session 4 (FOLLOW-UP 1): day 14 of the study The number of training sessions completed is recorded for each participant.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria: To be included patients must: • Have a breast or ovarian cancer diagnosis • Participants who have high levels of FCR (cut-off score of 13 or higher) or FoP (cut-off score of 34 and higher) • 18 years and older • Fluent in English • Have access to internet and computer competency • NOT receiving palliative care
Exclusion criteria
NONE